Lvosidenib (AK112)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lvosidenib (AK112), covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer [Phase 2]